top of page
Growth is the Only Evidence of Life
At Mynd, we are alive and growing. We are a biotech company focusing on defeating inflammation and would love to have more like-minded people be part of our investor community.
We strongly believe in supporting people suffering from neuroinflammatory diseases and we believe our research can help change lives.
Investor Relations
For more information contact:
Luke Warkentin, VP Corporate Development
We are Committed to Serving the Best Interests of our Shareholders
Anyone can invest, find out more below.
![shutterstock_756403858-[Converted].png](https://static.wixstatic.com/media/751e53_f24d109a5ec44806861464b65e3b8904~mv2.png/v1/fill/w_980,h_551,al_c,q_90,usm_0.66_1.00_0.01,enc_auto/751e53_f24d109a5ec44806861464b65e3b8904~mv2.png)
Press Releases
Interviews
Stay Informed on Key Developments
CSE: MYND / OTC: MYNDF
bottom of page